Trials / Completed
CompletedNCT01937676
LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,250 (actual)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is evaluate if K3, a novel biomarker, sampled at arrival to the emergency department can be used to predict the development of organ failure measured as SOFA score. K3 consists of lactate dehydrogenase, albumin and magnesium combined.
Conditions
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-04-01
- First posted
- 2013-09-09
- Last updated
- 2016-09-07
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01937676. Inclusion in this directory is not an endorsement.